Barclays and JP Morgan raise price targets on Intuitive Surgical shares
Barclays lifted its Intuitive Surgical target to $500 from $485, JP Morgan to $475 from $450. Dow Jones Newswires, citing Benzinga data.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Barclays analysts raised their price target on Intuitive Surgical shares to $500 from $485 and kept an Overweight rating. Dow Jones Newswires reports the move, citing Benzinga.
JP Morgan also revised its outlook, lifting its target to $475 from $450. Both changes were recorded on October 21, 2026, at 13:12 and 15:18 GMT.
why it matters
Price target revisions reflect analysts' expectations for the company's stock and usually do not signal an immediate move in the quote. For investors, they point to rising valuations from major brokers, but buy or sell decisions depend on many factors, and this text is not a recommendation.
tags
instruments
sources
- Intuitive Surgical Price Target Raised to $500.00/Share From $485.00 by Barclays — Dow Jones Newswires, 21 October 2026 at 13:12 UTC
- Intuitive Surgical Price Target Raised to $475.00/Share From $450.00 by JP Morgan — Dow Jones Newswires, 21 October 2026 at 15:18 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗